Common Contracts
19 similar Underwriting Agreement contracts by Scorpius Holdings, Inc., Advanced Biomed Inc., APRINOIA Therapeutics Inc., others
UNDERWRITING AGREEMENT between Wing Yip Food Holdings Group Limited and EF HUTTON LLC, as Representative of the Several Underwriters Wing Yip Food Holdings Group Limited UNDERWRITING AGREEMENTUnderwriting Agreement • May 17th, 2024 • Wing Yip Food Holdings Group LTD • Sausages & other prepared meat products • New York
The undersigned, Wing Yip Food Holdings Group Limited, a company with limited liability incorporated under the laws of Hong Kong (the “Company”), hereby confirms its agreement (this “Agreement”) with EF Hutton LLC (hereinafter referred to as the “Representative”), and with the other underwriters, if any, named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
2,000,000 Shares APRINOIA Therapeutics Inc. Ordinary Shares of Par Value US$0.40 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • May 17th, 2024 • APRINOIA Therapeutics Inc. • Pharmaceutical preparations • New York
APRINOIA Therapeutics Inc., an exempted company with limited liability incorporated in the Cayman Islands (the “Company”), proposes, subject to the terms and conditions in this agreement (the “Agreement”), to issue and sell to the several underwriters listed in Schedule I hereto (collectively, the “Underwriters”) an aggregate of 2,000,000 ordinary shares (the “Ordinary Shares”) of par value $0.40 per share of the Company (such Ordinary Shares are hereinafter referred to as the “Firm Shares”). At the option of the Underwriters, the Company agrees, subject to the terms and conditions herein, to issue and sell to the Underwriters up to an aggregate of 300,000 additional Ordinary Shares (the “Option Shares”). The Firm Shares and the Option Shares, are herein referred to collectively as the “Shares.” The respective number of Shares to be purchased by each Underwriter is set forth opposite its name in Schedule I hereto.
RAYTECH HOLDING LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • May 17th, 2024 • Raytech Holding LTD • Household appliances • New York
UNDERWRITING AGREEMENT between SCORPIUS HOLDINGS, INC. and THINKEQUITY LLCUnderwriting Agreement • May 16th, 2024 • Scorpius Holdings, Inc. • Pharmaceutical preparations • New York
The undersigned, Scorpius Holdings, Inc., a corporation formed under the laws of the Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
NANO NUCLEAR ENERGY INC. UNDERWRITING AGREEMENTUnderwriting Agreement • May 13th, 2024 • Nano Nuclear Energy Inc. • Electric services • New York
The undersigned, Nano Nuclear Energy Inc., a corporation formed under the laws of the State of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Nano Nuclear Energy Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with The Benchmark Company, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENT between SCORPIUS HOLDINGS, INC. and THINKEQUITY LLCUnderwriting Agreement • May 13th, 2024 • Scorpius Holdings, Inc. • Pharmaceutical preparations • New York
The undersigned, Scorpius Holdings, Inc., a corporation formed under the laws of the Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • May 6th, 2024 • WORK Medical Technology Group LTD • Surgical & medical instruments & apparatus • Florida
The undersigned, WORK Medical Technology Group LTD, a Cayman Islands exempted company (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of the Company, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters named herein (the “Underwriters” and each an “Underwriter”), for whom Kingswood, a division of Kingswood Capital Partners, LLC is acting as representative (in such capacity, the “Representative,” and if there are no underwriters other than the Representative, references to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) to issue and sell to the Underwriters an aggregate of 2,000,000 ordinary shares, par value $0.0005 per share (“Ordinary Shares”), of the Company to be sold by the Company (the “Firm Shares”
UNDERWRITING AGREEMENT between Fly-E Group, Inc. and The Benchmark Company, LLC as Representative of the Several Underwriters UNDERWRITING AGREEMENT between Fly-E Group, Inc. and The Benchmark Company, LLC as Representative of the Several UnderwritersUnderwriting Agreement • May 3rd, 2024 • Fly-E Group, Inc. • Motor vehicles & passenger car bodies • New York
UNDERWRITING AGREEMENT between SCORPIUS HOLDINGS, INC. and THINKEQUITY LLCUnderwriting Agreement • May 3rd, 2024 • Scorpius Holdings, Inc. • Pharmaceutical preparations • New York
The undersigned, Scorpius Holdings, Inc., a corporation formed under the laws of the Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • May 1st, 2024 • CleanCore Solutions, Inc. • Refrigeration & service industry machinery • New York
The undersigned, CleanCore Solutions, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Boustead Securities, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENT betweenUnderwriting Agreement • May 1st, 2024 • Wearable Devices Ltd. • Computer communications equipment • New York
The undersigned, Wearable Devices Ltd. (the “Issuer”), a company formed under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Wearable Devices Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
MINGTENG INTERNATIONAL CORPORATION INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2024 • Mingteng International Corp Inc. • Metal doors, sash, frames, moldings & trim • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2024 • CDT Environmental Technology Investment Holdings LTD • Sanitary services • New York
The undersigned, CDT Environmental Technology Investment Holdings Limited, a company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom WestPark Capital, Inc. is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, references to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 1,500,000 ordinary shares, $0.0025 par value per share (“Ordinary Shares”), of the Company (the “Firm Shares”). The Company has also granted to the Underwriters an option (the “Over-allotment Option”) to purchase up to 225,000 additional Ordinary Shares, on the terms and for the purposes set forth in Section 1(b) hereof (the
Advanced Biomed Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • November 20th, 2023 • Advanced Biomed Inc. • Services-medical laboratories • New York
UNDERWRITING AGREEMENT between CEL-SCI CORPORATION and THINKEQUITY LLC as Representative of the Several Underwriters CEL-SCI CORPORATIONUnderwriting Agreement • November 20th, 2023 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
The undersigned, CEL-SCI Corporation, a corporation formed under the laws of the State of Colorado (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of CEL-SCI Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
COR3 & Co. (Holdings) Limited UNDERWRITING AGREEMENTUnderwriting Agreement • November 20th, 2023 • COR3&Co. (Holdings) LTD • Apparel & other finishd prods of fabrics & similar matl • New York
This underwriting agreement (this “Agreement”) constitutes the agreement between COR3 & Co. (Holdings) Limited, a corporation incorporated under the laws of the Cayman Islands (the “Company”), and those certain shareholders of the Company named on Schedule II attached hereto (the “Selling Shareholders”) on the one hand, and Eddid Securities USA Inc. is acting as representative (in such capacity, the “Representative”) and such other underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), on the other hand, pursuant to which the Underwriter shall serve as the underwriter for the Company in connection with the proposed offering (the “Offering”) by the Company and the Selling Shareholder of the Shares (as defined below) on a “Firm Commitment” basis.
UNDERWRITING AGREEMENT between FENBO INDUSTRIES LIMITED and EF HUTTON, division of Benchmark Investments, LLC, as Representative of the Several Underwriters FENBO INDUSTRIES LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • October 27th, 2023 • Fenbo Holdings LTD • Electric housewares & fans • New York
The undersigned, Fenbo Industries Limited, a corporation formed under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with EF Hutton, division of Benchmark Investments, LLC (hereinafter referred to as the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
Advanced Biomed Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • October 27th, 2023 • Advanced Biomed Inc. • Services-medical laboratories • New York
